CompletedPhase 2NCT01709149
Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
Studying Amyotrophic lateral sclerosis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Cytokinetics
- Principal Investigator
- Jinsy Andrews, MDCytokinetics, Inc.
- Intervention
- CK-2017357(drug)
- Enrollment
- 711 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2012 – 2014
Study locations (30)
- Barrow Neurology, Phoenix, Arizona, United States
- University of California, San Diego, La Jolla, California, United States
- UC Irvine ALS & Neuromuscular Center, Orange, California, United States
- Coordinated Clinical Research, San Diego, California, United States
- California Pacific Medical Center Forbes Norris MDA/ALS Research Center, San Francisco, California, United States
- Hospital for Special Care, New Britain, Connecticut, United States
- The George Washington University, Washington D.C., District of Columbia, United States
- Mayo Clinic Florida Department of Neurology, Jacksonville, Florida, United States
- Emory University, School of Medicine, Atlanta, Georgia, United States
- Georgia Health Sciences University, Augusta, Georgia, United States
- Indiana University Department of Neurology, Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
- University of Kansas, Kansas City, Kansas, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01709149 on ClinicalTrials.govOther trials for Amyotrophic lateral sclerosis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07401186Stimulation-Based Modulation of Spinal and Cortical Sensory PathwaysPeter C. Gerszten, MD
- RECRUITINGNCT07467187Invasive Home Ventilation in DenmarkRigshospitalet, Denmark
- RECRUITINGNCT07502677Diagnostic Accuracy of SleepImage Technology for Detecting Respiratory Failure in Patients With Amyotrophic Lateral SclerosisRoyal Brompton & Harefield NHS Foundation Trust
- RECRUITINGNANCT07446114Functional Outcomes and Control Using Synchron BCI - CanadaSynchron, Inc.
- ENROLLING BY INVITATIONPHASE2, PHASE3NCT07410806HEALEY ALS Platform Trial - Regimen I NUZ-001Merit E. Cudkowicz, MD
- ENROLLING BY INVITATIONNANCT07298486Impact of Robotic Glove Use on Quality of Life, Grip Strength and Fine Motor Control in ALSNova Southeastern University
- ACTIVE NOT RECRUITINGPHASE1NCT07204977Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)National Institute of Neurological Disorders and Stroke (NINDS)
- RECRUITINGPHASE3NCT07322003Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALSPrilenia